[Investigation into the cause of re-stenosis after coronary bypass surgery].
Fujimoto
Yo
Y
Toranomon Hospital.
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D017222:Angioplasty, Balloon, Laser-Assisted; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D001055:Apolipoproteins B / Q000097:blood; D017225:Atherectomy, Coronary; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D008078:Cholesterol, LDL / Q000097:blood; D001026:Coronary Artery Bypass / Q000009:adverse effects; D023903:Coronary Restenosis / Q000209:etiology* / Q000628:therapy; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage; D008323:Mammary Arteries / Q000637:transplantation; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D012307:Risk Factors; D012501:Saphenous Vein / Q000637:transplantation
D000911:Antibodies, Monoclonal; D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab